We value your privacy
We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.
Clinical Trials
1
0 active
Approvals
0
Total approvals
Agencies
Regulatory bodies
Founded
1914
Completed
100.0%
No approval data available
- Toyobo Co., Ltd. and DMC Biotechnologies have signed a multi-year collaboration agreement to develop sustainable, fermentation-produced chemical intermediates for essential materials production. - The partnership combines DMC's proprietary Dynamic Metabolic Control™ technology with Toyobo's chemical synthesis and biotechnology expertise to create cost-effective bio-based chemical products. - The collaboration aims to address biomanufacturing's challenge of higher production costs compared to conventional chemical processes while reducing greenhouse gas emissions and fossil resource dependency. - Toyobo plans to utilize the optimized microorganisms and compounds as raw materials for its films and plastic products, supporting its Sustainable Vision 2030 goal of contributing to a decarbonized society.
